OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
November 08, 2006
Abbott's acquisition of Kos creates a viable contender in the fight for cardiovascular market share.
Judge defines term ahead of Medicare fraud trial.
After decades of disparate attempts to secure supply chains, pharma companies may finally be getting on the same page.